Product image of Denbrayce (Denosumab) supplied by GNH India

Denbrayce

Active Ingredient:
Denosumab
Origin:
EU

Denbrayce (Denosumab)

Denbrayce is a subcutaneous medication containing denosumab, used for bone health and osteoporosis management. Learn about its uses, effects, and precautions.

Manufacturer / TM Owner

Mabxience Research S.L.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Denbrayce is primarily used for the treatment of osteoporosis in postmenopausal women and men at high risk of fractures. It may also be used to increase bone mass in patients at high risk for fracture receiving certain treatments. Denosumab works by inhibiting a protein in the body that is involved in the breakdown of bone tissue. This helps to strengthen bones and reduce the risk of fractures.

Side Effects

  • Common effects of Denbrayce may include mild reactions at the injection site, such as redness, swelling, or itching. Some users may experience back pain, pain in extremities, high cholesterol, rash, or bladder infection. These effects are generally mild and temporary, but if they persist or worsen, consult a healthcare professional.

Precautions & Warnings

  • Denbrayce should be used with caution in patients with a history of low calcium levels in the blood. It is important to maintain adequate calcium and vitamin D intake while using this medication. Patients should also be monitored for signs of infection, as denosumab may increase the risk of certain infections. Always follow the advice of a healthcare professional regarding the use of Denbrayce.

Avoid Interactions

  • Denbrayce may interact with other medications, including those that affect the immune system. It is important to inform your healthcare professional about all medications you are taking before starting Denbrayce. Avoid alcohol while using this medication, as it may increase the risk of side effects. Always consult a healthcare professional before starting any new medication.

Frequently Asked Questions

Denbrayce is used to treat osteoporosis and increase bone mass in patients at high risk for fractures.

Denbrayce is administered via subcutaneous injection, typically every six months.

Common side effects include mild reactions at the injection site, back pain, and high cholesterol.

Denbrayce may interact with other medications, so it's important to consult a healthcare professional before combining treatments.

Long-term safety of Denbrayce should be discussed with a healthcare professional, as individual health conditions may vary.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Denosumab

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT